Lymphoma — Trials, FDA Actions & Pivotal Research
15 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Lymphoma.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Lymphoma trials
Recruiting trials by city
Cities where Lymphoma trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedPembrolizumab Combination Shows No Dose-Limiting Toxicities in Lymphoma· Mar 30, 2026· drug: Pembrolizumab
- Results postedLymphoma Respiratory Training Trial Terminated After Recruiting One Participant· Feb 27, 2026
- Results postedPembrolizumab Trial for PD-L1 DLBCL Shows 80% Overall Response Rate· Feb 20, 2026· drug: Pembrolizumab
- Results postedLeukemia Patients: Hospice Model Reduces Acute Care, Chemotherapy· Jan 15, 2026
- Primary completionPembrolizumab Phase 3 Trial for Relapsed/Refractory cHL Completes· Jan 14, 2026· drug: Pembrolizumab
2025
- Primary completionEpcoritamab Phase 3 R/R DLBCL Trial Scheduled for Primary Completion· Oct 13, 2025· drug: Epcoritamab
- Primary completionEpcoritamab Phase 3 Trial for R/R DLBCL Reaches Primary Completion· Oct 13, 2025· drug: Epcoritamab
- Results postedPembrolizumab Combo Shows High Response Rates in B-Cell Lymphoma Trial· Oct 2, 2025· drug: Pembrolizumab
- Results postedLymphoma Pain Management Intervention Trial Posts Feasibility Results· Sep 18, 2025
- Results postedHIV & Immunocompromised Patients: ImmunoCARE Trial Shows Reduced Care Costs· Aug 8, 2025
- Results postedNivolumab Combo Shows 1 CR in Relapsed/Refractory Hodgkin Lymphoma Trial· Aug 6, 2025· drug: Nivolumab
- Results postedMyoStrain® Trial Results Posted: Detecting Cardiotoxicity in Breast Cancer· Jul 29, 2025
- Results postedNivolumab: Safety Data Posted for Myeloma, Lymphoma Trial· Jul 25, 2025· drug: Nivolumab
- Results postedPembrolizumab Combination Trial: TTX-030 Shows Favorable Safety in Phase 1· Jul 2, 2025· drug: Pembrolizumab
- Results postedCancer Patients' Treatment Priorities Posted for Elderly and Young· Jul 1, 2025